Pseudomonas aeruginosa and cystic fibrosis:: first colonization to chronic infection

被引:0
|
作者
Laurans, M.
Arion, A.
Fines-Guyon, M.
Regeasse, A.
Brouard, J.
Leclercq, R.
Duhamel, J. F.
机构
[1] Serv Pediat, F-14033 Caen 05, France
[2] Microbiol Serv, F-14033 Caen, France
[3] Serv Informat CRCM Caen, F-14033 Caen 05, France
来源
ARCHIVES DE PEDIATRIE | 2006年 / 13卷
关键词
Pseudomonas aeruginosa; cystic fibrosis;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Pseudomonas aeruginosa (Pa) is the most common virulent respiratory pathogen in cystic fibrosis and is characterized by an important capacity of adaptation, adherence and communication. The factors of virulence of Pa play a major part in adherence with the respiratory epithelial cells and in occurrence of infectious episodes. The factors responsible for the transition of first Pa acquisition to the chronic infection are not elucidated yet. The system of secretion of type III and the quorum sensing (QS) play an important role. The QS would intervene in the maturation of the biofilm of Pa, responsible for the "mucoid" phenotype of Pa, associated to a degradation of the respiratory function. We made a retrospective study on the period 1984-2005 within the Center of Cystic fibrosis of Caen allow to determine the percentage of firstly-colonized and chronic infected patients with Pa according to age. At 6 months of life, 11% of the infants were colonized with Pa reaching 48% to 7 years and 85% at the 18 years age. The percentage of chronic children carrying Pa was 0% at 1 year, 11% at 4 years, 44% at 12 years and 74% at 18 years according to the method of Kaplan-Meier. Comparing the period 1984-1994 with that of 1995-2005, the firstly-colonization and the chronic carrying of Pa occurred earlier and significantly during the second period. The current objective, beside the respiratory care, comprises the maintenance of an optimal nutritional statute and, waiting for an effective vaccine, the development of new therapeutic targets in order to attenuate the virulence of the stocks of Pa and as much as possible to delay the age of firstly-colonization and the age of chronic colonization with mucoid Pa. (c) 2006 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:S22 / S29
页数:8
相关论文
共 50 条
  • [21] Specific genotypes determine the age of chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients
    Liechti-Gallati, S
    Aebi, C
    Kraemer, R
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A897 - A897
  • [22] MOLECULAR EPIDEMIOLOGY OF CHRONIC PULMONARY COLONIZATION BY PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    BOUKADIDA, J
    DEMONTALEMBERT, M
    LENOIR, G
    SCHEINMANN, P
    VERON, M
    BERCHE, P
    JOURNAL OF MEDICAL MICROBIOLOGY, 1993, 38 (01) : 29 - 33
  • [23] PREVENTION OF CHRONIC PSEUDOMONAS-AERUGINOSA COLONIZATION IN CYSTIC-FIBROSIS BY EARLY TREATMENT
    VALERIUS, NH
    KOCH, C
    HOIBY, N
    LANCET, 1991, 338 (8769): : 725 - 726
  • [24] Pseudomonas aeruginosa in cystic fibrosis: A chronic cheater
    Waters, Christopher M.
    Goldberg, Joanna B.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (14) : 6525 - 6527
  • [25] Eradication of initial pseudomonas aeruginosa colonization in patients with cystic fibrosis
    Griese, M
    Müller, I
    Reinhardt, D
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2002, 7 (02) : 79 - 80
  • [26] TREATMENT OF PSEUDOMONAS-AERUGINOSA COLONIZATION IN CYSTIC-FIBROSIS
    STEINKAMP, G
    TUMMLER, B
    MALOTTKE, R
    VONDERHARDT, H
    ARCHIVES OF DISEASE IN CHILDHOOD, 1989, 64 (07) : 1022 - 1028
  • [27] Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis
    Frederiksen, B
    Koch, C
    Hoiby, N
    PEDIATRIC PULMONOLOGY, 1997, 23 (05) : 330 - 335
  • [28] Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis
    Lebecque, Patrick
    Leal, Teresinha
    Zylberberg, Katia
    Reychler, Gregory
    Bossuyt, Xavier
    Godding, Veronique
    JOURNAL OF CYSTIC FIBROSIS, 2006, 5 (04) : 237 - 244
  • [29] The Costs of Treatment of Early and Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients
    Braccini, G.
    Festini, F.
    Boni, V.
    Neri, A. S.
    Galici, V.
    Campana, S.
    Zavataro, L.
    Trevisan, F.
    Braggion, C.
    Taccetti, G.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (02) : 188 - 192
  • [30] Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
    Bilton, Diana
    Pressler, Tacjana
    Fajac, Isabelle
    Clancy, John Paul
    Sands, Dorota
    Minic, Predrag
    Cipolli, Marco
    Galeva, Ivanka
    Sole, Amparo
    Quittner, Alexandra L.
    Liu, Keith
    McGinnis, John R., II
    Eagle, Gina
    Gupta, Renu
    Konstan, Michael W.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (02) : 284 - 291